Cervical Spondylosis
1
Pipeline Programs
7
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
PfizerPregabalin
Globus MedicalNuVasive® ACP System Study
Spine BioPharmaViviGen
Providence TherapeuticsDTRAX Graft
Clinical Trials (4)
Total enrollment: 225 patients across 4 trials
Pregabalin and Radicular Pain Study (PARPS)
Start: Jan 2008Est. completion: Apr 201050 patients
Phase 4Completed
NuVasive® ACP System Study
Start: May 2022Est. completion: Jun 202775 patients
N/AEnrolling By Invitation
An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix
Start: Jun 2016Est. completion: Apr 2021100 patients
N/ACompleted
Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease
Start: May 2012Est. completion: Feb 20150
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
7 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.